Skip to content

Clinical trials

Uterine Cervical Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Country / region: Hong Kong Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20091
20121
20141
20171
20181
20191
20201
20234
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status5
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Precision Robotics (Hong Kong) Limited2
Radiation Therapy Oncology Group2
The University of Hong Kong2
WomenX Biotech Limited2
GlaxoSmithKline1
MacroGenics1
Princess Margaret Hospital, Hong Kong1
RAPT Therapeutics, Inc., a member of the GSK plc group of companies1
University of Washington1
Yonsei University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms14
Ovarian Neoplasms4
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Endometrial Neoplasms2
Squamous Cell Carcinoma of Head and Neck2
Adenocarcinoma, Clear Cell1
Anxiety Disorders1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.